Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04651816 · ClinicalTrials.gov registry record · NA
Diabetes Prevention Program Pilot
A NA study of PreDiabetes, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04651816: Completed NA study of PreDiabetes, sponsored by Penn State University.
NCT04651816 is a NA study of PreDiabetes that has completed, run by Penn State University. The registered enrollment target is 30 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04651816, a NA study of PreDiabetes, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This initiative, which is a partnership between State College area Penn State Health ambulatory care clinics located off campus in the State College area, has two primary goals: 1) improve the health and quality of life of Penn State Health patients with pre-diabetes and 2) decrease associated health care costs due to type 2 diabetes and its complications. The results from the study may serve as a model for additional chronic disease prevention programs to implement in additional Penn State Health clinics in the future.
Primary Outcome
Patients will be monitored through out the study for healthy weight loss.
Conditions Studied
Interventions
- BEHAVIORAL Financial Incentives
- BEHAVIORAL Motivational Message
- BEHAVIORAL DPP Program
Study Locations (1)
Pennsylvania
- Penn State Health Medical Group -- Park Avenue - State College
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-05-25 |
| Est. Completion | 2023-08-08 |
| Phase | NA |
What the finished NCT04651816 record still lists
NCT04651816 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (96% lower).
The record links to 1 condition, with PreDiabetes appearing as the primary indexed condition, and to 3 interventions - of which Financial Incentives is the first listed.
NCT04651816 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04651816 about?
NCT04651816 is a clinical study titled "Diabetes Prevention Program Pilot". This initiative, which is a partnership between State College area Penn State Health ambulatory care clinics located off campus in the State College area, has two primary goals: 1) improve the health and quality of life of Penn State Health patients with pre-diabetes and 2) decrease associated healt...
What is the current status of trial NCT04651816?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-05-25. Estimated completion is 2023-08-08.
What conditions does trial NCT04651816 study?
This clinical trial studies the following conditions: PreDiabetes.
What interventions are being tested in trial NCT04651816?
The interventions under investigation include: Financial Incentives (BEHAVIORAL), Motivational Message (BEHAVIORAL), DPP Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04651816?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04651816 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04651816's enrollment target sits among peer trials
30 118th of 149 higher than 23 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Cleaner Air for Lower Cardiometabolic Risk
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI